LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab von Wu, Yahua, Du, Bin, Lv, Chengliu, Ji, Xiaohui, Lai, Jinhuo

Volltext

The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma von Wu, Yahua, Du, Bin, Lin, Mingqiang, Ji, Xiaohui, Lv, Chengliu, Lai, Jinhuo

Volltext

First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study von Wu, Yahua, Du, Bin, Lv, Chengliu, Ji, Xiaohui, Lan, Yanqin, Yao, Na, Zhu, Yingjiao, Lai, Jinhuo

Volltext

Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study von Lv, Chengliu, Wu, Yahua, Gu, Weiwei, Du, Bin, Yao, Na, Zhu, Yingjiao, Zheng, Jianping, Hong, Yaping, Lai, Jinhuo

Volltext

Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy von Wu, Yahua, Lv, Chengliu, Lin, Mingqian, Hong, Yaping, Du, Bin, Yao, Na, Zhu, Yingjiao, Ji, Xiaohui, Li, Jiancheng, Lai, Jinhuo

Volltext

Ribosomal protein L22 like 1: a promising biomarker for lung adenocarcinoma von Wu, Yahua, Yao, Na, Du, Bin, Zhu, Yingjiao, Ji, Xiaohui, Lv, Chengliu, Lai, Jinhuo

Volltext

Impact of the number of lymph node dissections and a novel risk stratification on the prognosis in elderly locally advanced esophageal adenocarcinoma von Wu, Yahua, Gu, Weiwei, Du, Bin, Lv, Chengliu, Yao, Na, Zhu, Yingjiao, Ouyang, Jingxiang, Lai, Jinhuo

Volltext